LH

Laboratory Corporation of America Holdings

Price

$268.91

return (12m)

p/e

24.74

p/bv

2.66

DIVIDEND YIELD

1.01%

LH price

Laboratory Corporation

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals LH

Valuation

P/E

24.74

Sector -2.34

Industry 11.10

P/BV

2.66

Sector 2.17

Industry 3.33

P/Revenue (PSR)

1.65

Sector 2.00

Industry 1.71

EV/EBITDA

51.36

Sector -23.69

Industry -398.52

EV/EBIT

75.10

Sector -36.60

Industry -80.73

P/EBITDA

11.29

Sector -0.10

Industry 8.30

P/EBIT

16.94

Sector -2.08

Industry 5.69

P/Total Assets

1.22

Sector 1.18

Industry 1.57

P/Net Current Assets

-4.03

Sector -10.91

Industry -3.38

P/Working Capital

12.15

Sector 0.09

Industry 10.51

EPS

11.48

Sector -0.93

Industry 1.10

BVPS

106.65

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

28.83%

Sector 44.28%

Industry 29.23%

EBITDA Margin

15.49%

Sector -291.45%

Industry 4.29%

EBIT Margin

10.59%

Sector -195.44%

Industry 1.44%

Operating Margin

11.11%

Sector -25.72%

Industry 2.16%

Net Profit Margins

6.66%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.19

Sector 0.12

Industry 0.27

Profitability

ROE

10.77%

Sector -34.71%

Industry 6.97%

ROA

4.93%

Sector -28.76%

Industry 2.97%

ROIC

8.12%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

1.01%

Sector -

Industry 0.01%

Payout

24.99%

Sector -

Industry 0.54%

Debt

Current Ratio

1.73

Sector 1.87

Industry 1.51

Net Debt / EBITDA

8.85

Sector -2.18

Industry -1.68

Net Debt / EBIT

12.95

Sector -0.74

Industry -7.00

Net Debt / Equity

0.55

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.67

Sector -0.64

Industry 0.35

Equity/Assets

0.46

Sector 0.43

Industry 0.46

Liabilities/Assets

0.54

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

1.49%

Sector -

Industry -

5Y Earnings CAGR

-16.91%

Sector -

Industry -

FAIR VALUE OF Laboratory Corporation ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$268.91

Fair Value

$165.97

Upside Return potential.

-38.28%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LH Laboratory Corporation of America Holdings	$268.91	23.05%	1.01%	24.74	2.66	10.77%	6.66%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LH Historical Dividends

current DY: 1.01%

5-year average DY: 1.10%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/27/2026	03/12/2026	0.72000000
Dividends	11/26/2025	12/11/2025	0.72000000
Dividends	08/28/2025	09/11/2025	0.72000000
Dividends	05/29/2025	06/11/2025	0.72000000
Dividends	02/27/2025	03/12/2025	0.72000000
Dividends	11/26/2024	12/13/2024	0.72000000
Dividends	08/29/2024	09/13/2024	0.72000000
Dividends	05/28/2024	06/12/2024	0.72000000
Dividends	02/27/2024	03/13/2024	0.72000000
Dividends	11/08/2023	12/12/2023	0.72000000
Dividends	08/08/2023	09/08/2023	0.72000000
Dividends	05/18/2023	06/08/2023	0.72000000
Dividends	02/23/2023	03/13/2023	0.72000000
Dividends	11/17/2022	12/09/2022	0.72000000
Dividends	08/18/2022	09/09/2022	0.72000000
Dividends	05/19/2022	06/09/2022	0.72000000

ABOUT Laboratory Corporation

Laboratory Corporation of America Holdings

Average Investor10 user rating

4.0 (0 people)

States of America

55 years

Founded: 1971

1991

Time since IPO - 35 years

75.500

Employees

Laboratory Corporation of America Holdings (States of America) is listed on the NYSE and has a market capitalization of $23.30 billion, with shareholders equity totaling $8.75 billion.

The company employs approximately 75.500 people and operates in the Saúde sector, within the Serviços e Fornecedores de Saúde industry.

Over the past 12 months, Laboratory Corporation of America Holdings reported $14.14 billion in revenue, generating net income of $941.50 million.

Key financial metrics include a P/E ratio of 24.74, a price-to-book (P/B) ratio of 2.66, and a trailing twelve-month dividend yield of 1.01%.

The company trades under the ticker LH.

Market cap

$23.30 billion

Net worth

$8.75 billion

$8,745,500,000.00

Assets

$19.09 billion

$19,087,100,000.00

Total Shares Outstanding

82.00 million

82,000,000

Average Daily Trading Volume

$621.08 Thousand

$621,080.06

Sector

Saúde

Industry

Serviços e Fornecedores de Saúde

revenue by Business Segment Laboratory Corporation

LH revenue and profits

Financial Results LH

DRAG THE FRAME TO SEE MORE DATA

LH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56